|
Designing an Efficient Model for Cost Management of Non-Surgical Cancer Treatment in Iran
|
A Mazinani   1, M Mirmohammadkhani2 , L Najafi2 |
1- Department of Healthcare Management, Semnan Branch, Islamic Azad University, Semnan, Iran , dr.mazinani.abbas@gmail.com
2- Department of Healthcare Management, Semnan Branch, Islamic Azad University, Semnan, Iran |
|
|
Abstract: (580 Views) |
Background & aim: Human health is a fundamental right and a valuable asset for all members of a society at any level and social class. The existence of a strong and stable health system in a country displays the all-round stability of that society. The three main characteristics for evaluating the performance of the health system include the health status of the community, citizens' satisfaction with the services provided by the health sector, and protection against financial risks. Therefore, the aim of the current research was to design an efficient model for cost management of non-surgical cancer treatment in Iran.
Methods: This was a descriptive-analytical study with a survey method conducted in 2018. The method of data collection was a library (through examining hospital records) and the tool used was a questionnaire. For this purpose, an available sample consisting of 50 elites from the fields of health service management and health economics was selected and were asked to answer the designed questionnaire. The data collected by means of the main statistics used in the Delphi technique were the central measurements (mean, median and mean) and dispersion index, standard deviation and interquartile range.
Results: The amount of extracted variances was 0.529 after management of visit costs, 0.518 after management of diagnosis costs, 0.494 after management of hospitalization costs, 0.496 after management of chemotherapy costs, and 0.501 after management of radiation therapy costs. These results indicated that the amount of extracted variances was higher than 0.5; moreover, all the AVE values of the model dimensions were lower than the combined reliability, as a result the, condition of convergent validity was established.
Conclusion: The results of the present study indicated that the costs of non-surgical cancer treatment could be classified into 5 main indicators, including the cost of visits, diagnosis, hospitalization, radiation therapy and chemotherapy.
|
|
| Keywords: cancer, non-surgical treatment, treatment cost management model, Delphi technique. |
|
|
Full-Text [PDF 560 kb]
(36 Downloads)
|
Type of Study: Applicable |
Subject:
Health Management
Received: 2023/02/22 | Accepted: 2024/01/7 | Published: 2024/01/16
|
|
|
|
|
|
|
| References |
1. Dickens C, Joffe M, Jacobson J, Venter F, Schüz J, Cubasch H, McCormack V. Stage at breast cancer diagnosis and distance from diagnostic hospital in a periurban setting: a South African public hospital case series of over 1,000 women. International journal of cancer. 2018 Nov 1;135(9):2173-82. [ DOI:10.1002/ijc.28861] [ PMID] [ ] 2. Gabriela Dieguez FS, Ferro C, Pyenson BS. A Multi-Year Look at the Cost Burden of Cancer Care, 2017. 3. Giordano SH, Niu J, Chavez‐MacGregor M, Zhao H, Zorzi D, Shih YC, Smith BD, Shen C. Estimating regimen‐specific costs of chemotherapy for breast cancer: Observational cohort study. Cancer. 2016 Nov 15;122(22):3447-55. [ DOI:10.1002/cncr.30274] [ PMID] [ ] 4. Gultekin M, Karaca MZ, Kucukyildiz I, Dundar S, Keskinkilic B, Turkyilmaz M. (2019) Mega Hpv laboratories for cervical cancer control: Challenges and recommendations from a case study of Turkey. Papillomavirus Res. Jun;7:118-122. [ DOI:10.1016/j.pvr.2019.03.002] [ PMID] [ ] 5. Hair Jr, J. F., Hult, G. T. M., Ringle, C., & Sarstedt, M. (2016). A primer on partial least squares structural equation modeling (PLS-SEM). Sage Publications. 6. Hair, J. F., Black, W. C., Babin, B. J., Anderson, R. E., & Tatham, R. L. (2006). Multivariate data analysis 6th Edition. New Jersey: Pearson Education. 7. Jalali M, khodabakhshikoolaee A. (2018) Relationship between health literacy and general health amongpatients with leukemia before bone marrow transplant; 1(1) :1-7. [ DOI:10.29252/ijca.1.1.1] 8. Mariotto AB, Robin Yabroff K, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. Journal of the National Cancer Institute. 2011 Jan 19;103(2):117-28. [ DOI:10.1093/jnci/djq495] [ PMID] [ ] 9. Micheli A, Coebergh JW, Mugno E, Massimiliani E, Sant M, Oberaigner W, et al. (2019); European health systems and cancer care. Ann Oncol,14 ( 5): 41-60. [ DOI:10.1093/annonc/mdg753] [ PMID] 10. Prager GW, Braga S, Bystricky B, Qvortrup C, Criscitiello C, Esin E, Sonke GS, Martínez GA, Frenel JS, Karamouzis M, Strijbos M. Global cancer control: responding to the growing burden, rising costs and inequalities in access. ESMO open. 2018 Feb 1;3(2):e000285. [ DOI:10.1136/esmoopen-2017-000285] [ PMID] [ ] 11. Sayani. A. (2019); Health Equity in National Cancer Control Plans: An Analysis of the Ontario Cancer Plan. Int J Health Policy Manag,8(9):550-556. [ DOI:10.15171/ijhpm.2019.40] [ PMID] [ ] 12. Sullivan R, Alatise OI, Anderson BO, Audisio R, Autier P, Aggarwal A, Balch C, Brennan MF, Dare A, D'Cruz A, Eggermont AM. Global cancer surgery: delivering safe, affordable, and timely cancer surgery. The lancet oncology. 2017 Sep 1;16(11):1193-224. [ DOI:10.1016/S1470-2045(15)00223-5] [ PMID] 13. Wallwiener M, Brucker SY, Wallwiener D. Multidisciplinary breast centres in Germany: a review and update of quality assurance through benchmarking and certification. Archives of gynecology and obstetrics. 2016 Jun;285(6):1671-83. [ DOI:10.1007/s00404-011-2212-3] [ PMID] [ ] 14. Weiser TG, Gawande A. Excess surgical mortality: strategies for improving quality of care.2017; 279-305. [ DOI:10.1596/978-1-4648-0346-8_ch16] [ PMID] 15. Wesselmann S, Winter A, Ferencz J, Seufferlein T, Post S. Documented quality of care in certified colorectal cancer centers in Germany: German Cancer Society benchmarking report for 2013. International journal of colorectal disease. 2016 Apr;29(4):511-8. [ DOI:10.1007/s00384-014-1842-x] [ PMID] 16. WHO. (2021). Cancer control: knowledge into action: WHO guides for effective programmes. 17. WHO. Assessing national capacity for the prevention and control of NCDs. 2018. 18. Zafar SY, Peppercorn JM, Schrag D, Taylor DH, Goetzinger AM, Zhong X, Abernethy AP. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. The oncologist. 2018 Apr;18(4):381. [ DOI:10.1634/theoncologist.2012-0279] [ PMID] [ ] |
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
|
|
